References
- 1ZesiewiczTAElbleRJLouisEDet alEvidence-based guideline update: treatment of essential tremor: report of the quality standards subcommittee of the American Academy of NeurologyNeurology2011771752175510.1212/WNL.0b013e318236f0fd22013182
- 2Benito-LeonJEssential tremor: a neurodegenerative diseaseTremor Other Hyperkinet Mov2014410.7916/D8763CG0
- 3LouisEDFaustPLVonsattelJ-PGPurkinje cell loss is a characteristic of essential tremor: towards a more mature understanding of pathogenesisParkinsonism Relat Disord2012181003100410.1016/j.parkreldis.2012.06.01722795481
- 4GironellAThe GABA hypothesis in essential tremor: lights and shadowsTremor Other Hyperkinet Mov2014410.7916/D8SF2T9C
- 5DeuschlGElbleREssential tremor: neurodegenerative or nondegenerative disease towards a working definition of ETMov Disord2009142033204110.1002/mds.2275519750493
- 6LlinasRVolkindRAThe olivo-cerebellar system: functional properties as revealed by harmaline-induced tremorExp Brain Res197318698710.1007/BF002365574746753
- 7HandforthAHomanicsGECoveyDFet alT-type calcium channel antagonists suppress tremor in two mouse models of essential tremorNeuropharmacology20105938038710.1016/j.neuropharm.2010.05.01220547167
- 8Marin-LahozJGironellALinking essential tremor to the cerebellum: neurochemical evidenceCerebellum20161524325210.1007/s12311-015-0735-z26498765
- 9CoulterDAHuguenardN
Jr PrinceDACharacterization of ethosuximide reduction of low-threshold calcium current in thalamic neuronsAnn Neurol19892558259310.1002/ana.4102506102545161 - 10DeuschlGBainPBrinMet alConsensus statement of the Movement Disorder Society on tremorMov Disord199813Suppl 322310.1002/mds.8701313039827589
- 11GironellAKulisevskyJPascual-SedanoBBarbanojMRoutine neurophysiological tremor analysis as a diagnostic tool for essential tremor: a prospective studyJ Clin Neurophysiol20042144645010.1097/00004691-200411000-0000915622132
- 12FahnSTolosaEMarínCClinical rating scale for tremorJankovicJTolosaEParkinson’s disease and movement disordersBaltimoreUrban & Shwarzenberg1988225234
- 13GironellAKulisevskyJBarbanojMLópez-VillegasDHernándezGPascualBA double-blind placebo-controlled trial of gabapentin and propranolol in patients with essential tremorArch Neurol19995647548010.1001/archneur.56.4.47510199338
- 14BainPGFindleyLJAtchinsonPet alAssessing tremor severityJ Neurol Neurosurg Psychiatry19935686887310.1136/jnnp.56.8.8688350102
- 15WilmsHSieversJDeuschlGAnimal models of tremorMov Disord19991455757110.1002/1531-8257(199907)14:4<;557:AID-MDS1004>3.0.CO;2-G10435492
- 16Gomez-MancillaBLatulippeJFBoucheerRBédardPJEffect of ethosuximide on rest tremor in the MPTP monkey modelMov Disord1992713714110.1002/mds.8700702071350061
- 17PourcherEGomez-MancillaBBédardPJEthosuximide and tremor in Parkinson’s disease: a pilot studyMov Disord1992713213610.1002/mds.8700702061350060